RetinalGenix Technologies Appoints Taimour Langaee as Scientific Advisor

APOLLO BEACH, Fla.—RetinalGenix Technologies Inc. (OTCQB:RTGN), a leader in advanced retinal imaging and precision medicine, has announced the appointment of Taimour Langaee, MSPH, Ph.D., as its newest scientific advisor. According to the announcement, Langaee will play a key role in advancing the company’s DNA GPS pharmacogenetics initiatives, which are designed to optimize personalized treatment pathways for retinal and systemic diseases through cutting-edge genetic biomarkers and high-resolution retinal imaging. He will oversee the genotyping/sequencing data processing, genetic and pharmacogenomics data analyses, and clinical genetic association studies between eye diseases and genetic variations, the announcement said.